AngioDynamics, Inc. Cost of Goods Sold (Deprecated 2018-01-31)
AngioDynamics, Inc. (ANGO) reported Cost of Goods Sold (Deprecated 2018-01-31) of $38.40 million for the 3-month period ending 2018-02-28, per its 10-Q filed 2018-04-05.
Discontinued › Expense Statement
us-gaap:CostOfGoodsSold · last filed 2018-04-05
- AngioDynamics, Inc. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2018-02-28 was $38.40M, a 8.15% decline year-over-year.
- AngioDynamics, Inc. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-11-30 was $43.98M, a 0.10% decline year-over-year.
- AngioDynamics, Inc. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-08-31 was $44.18M, a 2.59% increase year-over-year.
- AngioDynamics, Inc. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-05-31 was $44.58M, a 14.09% decline year-over-year.
- AngioDynamics, Inc. cost of goods sold (deprecated 2018-01-31) for fiscal 2017 was $173.47M, a 3.40% decline from fiscal 2016.
- AngioDynamics, Inc. cost of goods sold (deprecated 2018-01-31) for fiscal 2016 was $179.57M, a 0.64% decline from fiscal 2015.
- AngioDynamics, Inc. cost of goods sold (deprecated 2018-01-31) for fiscal 2015 was $180.74M, a 3.72% increase from fiscal 2014.
- AngioDynamics, Inc. cost of goods sold (deprecated 2018-01-31) for fiscal 2014 was $174.25M, a 0.49% increase from fiscal 2013.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 3 month | Cost of Goods Sold (Deprecated 2018-01-31) 3 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 6 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 9 month | Cost of Goods Sold (Deprecated 2018-01-31) 9 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 12 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-02-28 | $38.40M 10-Q · filed 2018-04-05 | $82.38M derived: sum of 2 quarters · filed 2018-04-05 | $126.56M 10-Q · filed 2018-04-05 | $171.14M derived: sum of 4 quarters · filed 2018-04-05 | ||||
| 2017-11-30 | $43.98M 10-Q · filed 2018-01-05 | $88.16M 10-Q · filed 2018-01-05 | $132.74M derived: sum of 3 quarters · filed 2018-01-05 | $174.55M derived: sum of 4 quarters · filed 2018-04-05 | ||||
| 2017-08-31 | $44.18M 10-Q · filed 2017-09-29 | $88.76M derived: sum of 2 quarters · filed 2017-09-29 | $130.57M derived: sum of 3 quarters · filed 2018-04-05 | $174.59M derived: sum of 4 quarters · filed 2018-04-05 | ||||
| 2017-05-31 | $44.58M derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-04 | $86.39M derived: sum of 2 quarters · filed 2018-04-05 | $130.41M derived: sum of 3 quarters · filed 2018-04-05 | $173.47M 10-K · filed 2017-08-04 | ||||
| 2017-02-28 | $41.81M 10-Q · filed 2018-04-05 | $85.83M derived: sum of 2 quarters · filed 2018-04-05 | $128.90M 10-Q · filed 2018-04-05 | $180.79M derived: sum of 4 quarters · filed 2018-04-05 | ||||
| 2016-11-30 | $44.02M 10-Q · filed 2018-01-05 | $87.08M 10-Q · filed 2018-01-05 | $138.98M derived: sum of 3 quarters · filed 2018-01-05 | $182.88M derived: sum of 4 quarters · filed 2018-01-05 | ||||
| 2016-08-31 | $43.07M 10-Q · filed 2017-09-29 | $94.96M derived: sum of 2 quarters · filed 2017-09-29 | $138.86M derived: sum of 3 quarters · filed 2017-09-29 | $182.26M derived: sum of 4 quarters · filed 2017-09-29 | ||||
| 2016-05-31 | $51.89M derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-04 | $95.79M derived: sum of 2 quarters · filed 2017-08-04 | $139.19M derived: sum of 3 quarters · filed 2017-08-04 | $179.57M 10-K · filed 2017-08-04 | ||||
| 2016-02-29 | $43.90M 10-Q · filed 2017-04-03 | $87.30M derived: sum of 2 quarters · filed 2017-04-03 | $127.68M 10-Q · filed 2017-04-03 | $127.83M 10-Q · filed 2016-04-11 | $173.05M derived: sum of 4 quarters · filed 2017-04-03 | |||
| 2015-11-30 | $43.40M 10-Q · filed 2017-01-06 | $83.78M 10-Q · filed 2017-01-06 | $83.93M 10-Q · filed 2016-01-08 | $129.15M derived: sum of 3 quarters · filed 2017-01-06 | $178.07M derived: sum of 4 quarters · filed 2017-01-06 | |||
| 2015-08-31 | $40.38M 10-Q · filed 2016-10-05 | $40.53M 10-Q · filed 2015-10-08 | $85.75M derived: sum of 2 quarters · filed 2016-10-05 | $134.67M derived: sum of 3 quarters · filed 2016-10-05 | $179.99M derived: sum of 4 quarters · filed 2016-10-05 | |||
| 2015-05-31 | $45.37M 10-K · filed 2016-08-01 | $94.29M derived: sum of 2 quarters · filed 2016-08-01 | $139.61M derived: sum of 3 quarters · filed 2016-08-01 | $180.74M 10-K · filed 2017-08-04 | $180.09M 10-K · filed 2015-08-10 | |||
| 2015-02-28 | $48.92M 10-K · filed 2016-08-01 | $48.75M 10-Q · filed 2015-04-09 | $94.25M derived: sum of 2 quarters · filed 2016-08-01 | $135.37M 10-K · filed 2016-08-01 | $134.75M 10-Q · filed 2015-04-09 | $182.02M derived: sum of 4 quarters · filed 2016-08-01 | ||
| 2014-11-30 | $45.32M 10-K · filed 2016-08-01 | $44.49M 10-Q · filed 2015-01-09 | $86.45M 10-K · filed 2016-08-01 | $86.00M 10-Q · filed 2015-01-09 | $133.10M derived: sum of 3 quarters · filed 2016-08-01 | $176.46M derived: sum of 4 quarters · filed 2016-08-01 | ||
| 2014-08-31 | $41.13M 10-K · filed 2016-08-01 | $41.51M 10-Q · filed 2014-10-15 | $87.78M derived: sum of 2 quarters · filed 2016-08-01 | $131.13M derived: sum of 3 quarters · filed 2016-08-01 | $174.82M derived: sum of 4 quarters · filed 2016-08-01 | |||
| 2014-05-31 | $46.65M 10-K · filed 2015-01-12 | $90.01M derived: sum of 2 quarters · filed 2015-04-09 | $133.69M derived: sum of 3 quarters · filed 2015-04-09 | $174.25M 10-K · filed 2016-08-01 | $174.59M 10-K · filed 2014-08-14 | |||
| 2014-02-28 | $42.56M 10-Q · filed 2014-04-09 | $87.04M derived: sum of 2 quarters · filed 2015-04-09 | $128.11M 10-Q · filed 2015-04-09 | $127.34M 10-Q · filed 2014-04-09 | $174.26M derived: sum of 4 quarters · filed 2015-08-10 | |||
| 2013-11-30 | $43.69M 10-Q · filed 2015-01-09 | $84.75M 10-Q · filed 2015-01-09 | $84.78M 10-Q · filed 2014-01-09 | $130.91M derived: sum of 3 quarters · filed 2015-08-10 | $171.28M derived: sum of 4 quarters · filed 2015-08-10 | |||
| 2013-08-31 | $41.06M 10-Q · filed 2014-10-15 | $41.10M 10-Q · filed 2013-10-10 | $87.22M derived: sum of 2 quarters · filed 2015-08-10 | $127.59M derived: sum of 3 quarters · filed 2015-08-10 | $170.51M derived: sum of 4 quarters · filed 2015-08-10 | |||
| 2013-05-31 | $46.16M derived: 10-K 12 month − 10-Q 9 month · filed 2015-08-10 | $86.53M derived: sum of 2 quarters · filed 2015-08-10 | $129.44M derived: sum of 3 quarters · filed 2015-08-10 | $173.40M 10-K · filed 2015-08-10 | $173.04M 10-K · filed 2013-08-14 | |||
| 2013-02-28 | $40.37M 10-Q · filed 2013-04-09 | $83.29M derived: sum of 2 quarters · filed 2014-04-09 | $127.25M 10-Q · filed 2014-04-09 | $154.54M derived: sum of 4 quarters · filed 2015-01-12 | ||||
| 2012-11-30 | $42.92M 10-Q · filed 2014-01-09 | $86.88M 10-Q · filed 2013-01-09 | $114.17M derived: sum of 3 quarters · filed 2015-01-12 | $136.32M derived: sum of 4 quarters · filed 2015-01-12 | ||||
| 2012-08-31 | $41.06M 10-Q · filed 2015-01-09 | $43.95M 10-Q/A · filed 2012-11-09 | $71.25M derived: sum of 2 quarters · filed 2015-01-12 | $93.40M derived: sum of 3 quarters · filed 2015-01-12 | $118.27M derived: sum of 4 quarters · filed 2015-01-12 | |||
| 2012-05-31 | $27.30M derived: 10-K 12 month − 10-Q 9 month · filed 2015-01-12 | $49.45M derived: sum of 2 quarters · filed 2015-01-12 | $74.32M derived: sum of 3 quarters · filed 2015-01-12 | $96.61M 10-K · filed 2015-01-12 | $95.83M 10-K · filed 2012-08-14 | |||
| 2012-02-29 | $22.15M 10-Q · filed 2013-04-09 | $47.02M derived: sum of 2 quarters · filed 2013-04-09 | $69.31M 10-Q · filed 2013-04-09 | $93.10M derived: sum of 4 quarters · filed 2015-01-12 | ||||
| 2011-11-30 | $24.87M 10-Q · filed 2013-01-09 | $47.15M 10-Q · filed 2013-01-09 | $70.95M derived: sum of 3 quarters · filed 2015-01-12 | $93.88M derived: sum of 4 quarters · filed 2015-01-12 | ||||
| 2011-08-31 | $22.29M 10-Q/A · filed 2012-11-09 | $46.08M derived: sum of 2 quarters · filed 2015-01-12 | $69.01M derived: sum of 3 quarters · filed 2015-01-12 | $90.84M derived: sum of 4 quarters · filed 2015-01-12 | ||||
| 2011-05-31 | $23.80M derived: 10-K 12 month − 10-Q 9 month · filed 2015-01-12 | $46.72M derived: sum of 2 quarters · filed 2015-01-12 | $68.56M derived: sum of 3 quarters · filed 2015-01-12 | $90.05M 10-K · filed 2015-01-12 | ||||
| 2011-02-28 | $22.93M 10-Q · filed 2012-04-09 | $44.76M derived: sum of 2 quarters · filed 2012-04-09 | $66.25M 10-Q · filed 2012-04-09 | |||||
| 2010-11-30 | $21.84M 10-Q · filed 2012-01-05 | $43.32M 10-Q · filed 2012-01-05 | ||||||
| 2010-08-31 | $21.49M 10-Q · filed 2011-10-11 | |||||||
| 2010-05-31 | $89.07M 10-K · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |